3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Motor Activity
55
Breast Neoplasms
30
Neoplasms
25
Lung Neoplasms
8
Colorectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Fatigue
6
Colonic Neoplasms
6
Polycystic Ovary Syndrome
5
Pancreatic Neoplasms
5
Obesity
5
Multiple Myeloma
5
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Lymphedema
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Stomach Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Peripheral Nervous System Diseases
3
Hematologic Neoplasms
3
Endometrial Neoplasms
3
Skin Neoplasms
2
Sarcopenia
2
Recurrence
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Interventions
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
Therapeutics
1
Specimen Handling
1
Pluvicto
1
Peripheral Blood Stem Cell Transplantation
1
Interleukin-8
1
HuMax-IL8
1
Granulocyte Colony-Stimulating Factor
1
Genetic Counseling
1
Filgrastim
1
Exercise
1
Emapalumab
1
Decitabine
1
DNA
1
Cyclophosphamide
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytopenia
×
Exercise
×
1 year
×
Clear all
NCT06773871
2025-08-19
HemEx
Rigshospitalet, Denmark
Phase NA
Recruiting
36 enrolled